Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
san francisco blog main
boston blog main
boston top stories
national top stories
new york top stories
san francisco top stories
biotech ipos
boston
fda
rare disease drugs
23andme
acute migrane
acute myeloid leukemia
aligos therapeutics
alx oncology
ancestrydna
artificial intelligence
astellas pharma
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
bain capital
baker brothers life sciences
bausch health
benzodiazepine
berkeley lights
big data
blackstone group
blepharitis
bluebird bio
breast cancer
cancer drugs
cancer immunotherapy
cavion
What
ipos
5
×
ipo
ago
biotech
biotechs
companies
days
drug
hasn’t
medicines
prep
raised
research
slowed
achieve
activity
age
apparently
arrival
billion
catalyst
central
cns
combined
considering
data
diseases
disorder
dog
drugs
dyne
early
emerged
expected
experimental
eyes
firm
genetic
glitters
gold
Language
unset
5
×
Current search:
ipos
×
unset
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@techcrunch.com
4 years ago
All that glitters is not gold: How healthtech startups can achieve true value
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs